
MESO vs NVAX
$MESO vs $NVAX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MESO vs NVAX: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·Both are in downtrends, below their 50- and 200-day averages, so neither has turned up yet.
- ·Only NVAX beat the market over the past year, by 13.5%, while MESO trailed the S&P 500 at +8.8% by 33.6%.
- ·The last month has flipped the order: MESO has held up better over the month (-12.9% against -29.6%) even though NVAX leads over the year.
- ·NVAX has support 7.3% below at $7.08; MESO has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
MESO vs NVAX: the quick read
- ·MESO is the larger company by market cap ($1.51B vs $1.31B).
- ·NVAX has been more active on our scanner (201 vs 67 alerts in 30 days).
- ·MESO has the smaller float (129.9M vs 154.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (Biological Products, (No Diagnostic Substances) vs BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)), so they answer to different catalysts and a move in one says little about the other.
- ·NVAX draws far more of our scanner's attention, 201 unusual-volume alerts in 30 days against 67, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 15% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·NVAX pays a dividend and MESO does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching MESO or NVAX? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MESO and NVAX on TheDesperateTrader.
- Is MESO or NVAX the better stock?
- "Better" depends on your goal, and these two are not alike. MESO is the larger company by market cap ($1.51B vs $1.31B). NVAX has been more active on our scanner (201 vs 67 alerts in 30 days). MESO has the smaller float (129.9M vs 154.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MESO and NVAX?
- The differences that matter: they are not in the same business - MESO is biological products, (no diagnostic substances) and NVAX is biological products, (no diagnostic substances); they are similar in size ($1.51B vs $1.31B); they trade at very different share prices ($11.14 vs $7.64); MESO sits at -5% of its 52-week range against 20% for NVAX; only NVAX pays a dividend; our scanner flagged MESO 67 times in the last 30 days against 201 for NVAX. Everything above is measured from the latest completed session and SEC filings.
- Which of MESO and NVAX is more active right now?
- Right now MESO is at about 0.5x its normal volume and NVAX is at about 0.5x, so NVAX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is MESO or NVAX in the stronger trend?
- MESO is below its 50-day average of $13.96 and below its 200-day average of $15.10; NVAX is below its 50-day average of $10.38 and below its 200-day average of $9.32. NVAX leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MESO or NVAX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MESO and NVAX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.